Coronary Microvascular Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.patients with angina-like chest pain; 2.patients who underwent recent related examinations, such as electrocardiography (ECG), coronary angiography (CAG), computed tomographic angiography (CTA), echocardiography, and myocardial enzyme levels; 3.patients were highly suspected to have CMVD by cardiologists;
Exclusion criteria
Exclusion criteria: 1.allergies to adenosine; 2.patients who had non-cardiac cause for their chest discomfort; 3.systolic blood pressure <12.0 kPa, heart rate <40 bpm, severe arrhythmia, high-grade atrioventricular block, asthma or chronic obstructive pulmonary disease; 4.acute myocardial infarction, acute myocarditis, pericarditis, or endocarditis; 5.acute systemic disease or infection, uncontrolled metabolic disease, or severe hepatic or renal dysfunction; 6.pregnant or lactating women;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Myocardial blood flow quantitative values; | — |
Secondary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiovascular Events;Therapy response; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology